Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development

By: TalkMarkets

February 04, 2023 at 16:00 PM EST

Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a co-founder of Structure Therapeutics.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development

Popular Pages